Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance
Open accessThe DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Increased activity of the innate immune system has been implicated in the pathogenesis of the dyslipidemia and insulin resistance associated with obesity and type 2 diabetes. In this study, we addressed the potential role of Kupffer cells (liver-specific macrophages, KCs) in these metabolic abnormalities. RESEARCH DESIGN AND METHODS: Rats were depleted of KCs by administration of gadolinium chloride, after which all animals were exposed to a 2-week high-fat or high-sucrose diet. Subsequently, the effects of these interventions on the development of hepatic insulin resistance and steatosis were assessed. In further studies, the effects of M1-polarized KCs on hepatocyte lipid metabolism and insulin sensitivity were addressed. RESULTS: As expected, a high-fat or high-sucrose diet induced steatosis and hepatic insulin resistance. However, these metabolic abnormalities were prevented when liver was depleted of KCs. In vitro, KCs recapitulated the in vivo effects of diet by increasing hepatocyte triglyceride accumulation and fatty acid esterification, and decreasing fatty acid oxidation and insulin responsiveness. To address the mechanisms(s) of KC action, we inhibited a panel of cytokines using neutralizing antibodies. Only neutralizing antibodies against tumor necrosis factor-α (TNFα) attenuated KC-induced alterations in hepatocyte fatty acid oxidation, triglyceride accumulation, and insulin responsiveness. Importantly, KC TNFα levels were increased by diet in vivo and in isolated M1-polarized KCs in vitro. CONCLUSIONS: These data demonstrate a role for liver macrophages in diet-induced alterations in hepatic lipid metabolism and insulin sensitivity, and suggest a role for these cells in the etiology of the metabolic abnormalities of obesity/type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![FIG. 2. The effects of KC depletion on the development of liver insulin resistance on a high-fat or high-sucrose diet. Male Wistar rats depleted of KCs or control rats were exposed to a high-fat (A and B) or high-sucrose (C and D) diet for 2 weeks. Subsequently, animals were fasted overnight and then underwent 4 mU · kg−1 · min−1 euglycemic-hyperinsulinemic clamp in the presence of [3-H3]-glucose for the measurement of hepatic insulin sensitivity as described in research design and methods. Hepatic glucose output (A and C) and insulin suppression of hepatic glucose output (B and D) were assessed. Data are presented as means ± SE. Statistical significance is indicated. n = a minimum of four in each group.](https://figures.cochat.ai/paper-figures/1d7aea5fb96a40b789899a32b10fa965/depletion-of-liver-kupffer-cells-prevents-the-development-of-diet-induced-figure-2.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Not surprisingly, depleting hepatic macrophages in mouse models with agents such as clodronate liposomes, or blocking their recruitment pharmacologically, as with the CCR2/CCR5 antagonist Cenicriviroc, attenuate fibrosis and blunt other histologic markers of disease (87–91).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [88]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Cited by
Items 101–200 of 520
Lanthier, N., Molendi‐Coste, O., Cani, P. D., van Rooijen, N., Horsmans, Y., & Leclercq, I. A. (2011) · The FASEB Journal · doi:10.1096/fj.11-189472 · Cited by 127
MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis
Su, Q., Kumar, V., Sud, N., & Mahato, R. I. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.009 · Cited by 138
Mu, W., Cheng, X.-F., Liu, Y., Lv, Q.-Z., Liu, G.-L., Zhang, J.-G., & Li, X.-Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01566 · Cited by 123
The role of the gut microbiota in health and cardiovascular diseases
Wang, L., Wang, S., Zhang, Q., He, C., Fu, C., & Wei, Q. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00091-2 · Cited by 122
Luo, X.-Y., Takahara, T., Kawai, K., Fujino, M., Sugiyama, T., Tsuneyama, K., Tsukada, K., Nakae, S., Zhong, L., & Li, X.-K. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00193.2013 · Cited by 120
How Inflammation Impinges on NAFLD: A Role for Kupffer Cells
Duarte, N., Coelho, I. C., Patarrão, R. S., Almeida, J. I., Penha-Gonçalves, C., & Macedo, M. P. (2015) · BioMed Research International · doi:10.1155/2015/984578 · Cited by 120
Fuentes, L., Rőszer, T., & Ricote, M. (2010) · Mediators of Inflammation · doi:10.1155/2010/219583 · Cited by 119
Mantell, B. S., Stefanovic-Racic, M., Yang, X., Dedousis, N., Sipula, I. J., & O'Doherty, R. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019831 · Cited by 118
Self-citationRole and function of macrophages in the metabolic syndrome
Bhargava, P., & Lee, C.-H. (2012) · Biochemical Journal · doi:10.1042/bj20111708 · Cited by 114
Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes
Sahini, N., & Borlak, J. T. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.02.002 · Cited by 126
Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis
Li, H., Zhou, Y., Wang, H., Zhang, M., Qiu, P., Zhang, M., Zhang, R., Zhao, Q., & Liu, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01169 · Cited by 114
Liver macrophages regulate systemic metabolism through non-inflammatory factors
Morgantini, C., Jager, J., Li, X., Levi, L., Azzimato, V., Sulen, A., Barreby, E., Xu, C., Tencerová, M., Näslund, E. B., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0044-9 · Cited by 124
Li, Y., Huang, B., Jiang, X., Chen, W., Zhang, J., Wei, Y., Chen, Y., Lian, M., Bian, Z., Miao, Q., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01994 · Cited by 107
Suzuki, T., Shinjo, S., Arai, T., Kanai, M., & Goda, N. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15087 · Cited by 119
Caputo, T., Gilardi, F., & Desvergne, B. (2017) · FEBS Letters · doi:10.1002/1873-3468.12742 · Cited by 122
CD4+ T cell activation and inflammation in NASH-related fibrosis
Zhou, Y., Zhang, H., Yao, Y., Zhang, X., Guan, Y., & Zheng, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.967410 · Cited by 106
Magee, N., Zou, A., & Zhang, Y. (2016) · BioMed Research International · doi:10.1155/2016/5170402 · Cited by 107
Zhang, J., Zhang, H., Deng, X., Zhang, N., Liu, B., Xin, S., Li, G., & Xu, K. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.11.027 · Cited by 106
Sato, Y., Matsui, H., Yamamoto, N., Sato, R., Munakata, T., Kohara, M., & Harashima, H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.044 · Cited by 105
Kiefer, F. W., Neschen, S., Pfau, B., Legerer, B., Neuhofer, A., Kahle, M., Hrabé de Angelis, M., Schlederer, M., Mair, M., Kenner, L., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2170-0 · Cited by 104
Non-alcoholic steatohepatitis induces transient changes within the liver macrophage pool
Devisscher, L., Scott, C. L., Lefere, S., Raevens, S., Bogaerts, E., Paridaens, A., Verhelst, X., Geerts, A. M., Guilliams, M., & Vlierberghe, H. V. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.006 · Cited by 111
Han, Y., Ling, Q., Wu, L. M., Wang, X., Wang, Z., Chen, J., Zheng, Z., Zhou, Z., Jia, L., Li, L., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2221485 · Cited by 117
Fricker, Z. P., Pedley, A., Massaro, J. M., Vasan, R. S., Hoffmann, U., Benjamin, E. J., & Long, M. T. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.11.037 · Cited by 110
Emerging Role of Mast Cells and Macrophages in Cardiovascular and Metabolic Diseases
Xu, J., & Shi, G. (2012) · Endocrine Reviews · doi:10.1210/er.2011-0013 · Cited by 113
Ge, Q., Brichard, S., Yi, X., & Li, Q. (2014) · Journal of Immunology Research · doi:10.1155/2014/987285 · Cited by 102
Bu, L., Gao, M., Qu, S., & Liu, D. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9501-7 · Cited by 112
Denaës, T., Lodder, J., Chobert, M.-N., Ruiz, I., Pawlotsky, J.-M., Lotersztajn, S., & Teixeira-Clerc, F. (2016) · Scientific Reports · doi:10.1038/srep28806 · Cited by 100
Wu, H., Ni, X., Xu, Q., Wang, Q., Li, X., & Hua, J. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15025 · Cited by 105
Shen, H., Sheng, L., Chen, Z., Jiang, L., Su, H., Yin, L., Omary, M. B., & Rui, L. (2014) · Hepatology · doi:10.1002/hep.27348 · Cited by 96
Galic, S., Sachithanandan, N., Kay, T. W., & Steinberg, G. R. (2014) · Biochemical Journal · doi:10.1042/bj20140143 · Cited by 99
Etienne-Mesmin, L., Vijay-Kumar, M., Gewirtz, A. T., & Chassaing, B. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.04.007 · Cited by 98
The Multifaceted Roles of Macrophages in NAFLD Pathogenesis
Vonderlin, J., Chavakis, T., Sieweke, M., & Tacke, F. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.03.002 · Cited by 96
The Role of Myeloid-Derived Cells in the Progression of Liver Disease
Weston, C. J., Zimmermann, H. W., & Adams, D. H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00893 · Cited by 95
Thibaut, R., Gage, M. C., Pineda‐Torra, I., Chabrier, G., Venteclef, N., & Alzaid, F. (2022) · The FEBS Journal · doi:10.1111/febs.15877 · Cited by 95
Hoo, R. L. C., Lee, I. P. C., Zhou, M., Wong, J. Y. L., Hui, X. H., Xu, A., & Lam, K. S. L. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.022 · Cited by 94
Liver innate immune cells and insulin resistance: the multiple facets of Kupffer cells
Jager, J., Aparicio‐Vergara, M., & Aouadi, M. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12483 · Cited by 90
Xu, L., Nagata, N., & Ota, T. (2018) · Adipocyte · doi:10.1080/21623945.2018.1474669 · Cited by 98
Major roles of kupffer cells and macrophages in NAFLD development
Park, S., Diaz, J. G., Um, E., & Hahn, Y. S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1150118 · Cited by 98
Xanthine Oxidase Inhibition Attenuates Insulin Resistance and Diet-Induced Steatohepatitis in Mice
Nishikawa, T., Nagata, N., Shimakami, T., Shirakura, T., Matsui, C., Ni, Y., Zhuge, F., Xu, L., Chen, G., Nagashimada, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-020-57784-3 · Cited by 89
Diehl, K. L., Vorac, J., Hofmann, K., Meiser, P., Unterweger, I. A., Kuerschner, L., Weighardt, H., Förster, I., & Thiele, C. (2020) · Cells · doi:10.3390/cells9102258 · Cited by 96
Han, Y.-H., Kim, H.-J., Kim, E.-J., Kim, K.-S., Hong, S., Park, H.-G., & Lee, M.-O. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5655 · Cited by 84
Eckert, C., Klein, N., Kornek, M., & Lukacs-Kornek, V. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00179 · Cited by 83
Gotoh, K., Inoue, M., Masaki, T., Chiba, S., Shimasaki, T., Ando, H., Fujiwara, K., Katsuragi, I., Kakuma, T., Seike, M., et al. (2012) · Diabetes · doi:10.2337/db11-1688 · Cited by 86
Nishio, T., Taura, K., Iwaisako, K., Koyama, Y., Tanabe, K., Yamamoto, G., Okuda, Y., Ikeno, Y., Yoshino, K., Kasai, Y., et al. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-016-1304-z · Cited by 82
Xu, L., Chen, Y., Nagashimada, M., Ni, Y., Zhuge, F., Chen, G., Li, H., Pan, T., Yamashita, T., Mukaida, N., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154914 · Cited by 81
Tang, T., Sui, Y., Lian, M., Li, Z., & Hua, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081949 · Cited by 82
Sachithanandan, N., Graham, K. L., Galic, S., Honeyman, J. E., Fynch, S. L., Hewitt, K. A., Steinberg, G. R., & Kay, T. W. (2011) · Diabetes · doi:10.2337/db11-0259 · Cited by 81
Rowe, A., Zhang, L. Y., & Ramzan, I. M. (2011) · Advances in Pharmacological Sciences · doi:10.1155/2011/326724 · Cited by 88
Hepatic Stellate Cell-Immune Interactions in NASH
Carter, J. K., & Friedman, S. L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.867940 · Cited by 79
Wada, T., Miyashita, Y., Sasaki, M., Aruga, Y., Nakamura, Y., Ishii, Y., Sasahara, M., Kanasaki, K., Kitada, M., Koya, D., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00419.2013 · Cited by 79
MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic target
Ma, C., Zhang, Q., & Greten, T. F. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104295 · Cited by 81
Ying, W., Mahata, S., Bandyopadhyay, G. K., Zhou, Z., Wollam, J., Vu, J., Mayoral, R., Chi, N., Webster, N. J. G., Corti, A., et al. (2018) · Diabetes · doi:10.2337/db17-0788 · Cited by 78
Hemolysis transforms liver macrophages into antiinflammatory erythrophagocytes
Pfefferlé, M., Ingoglia, G., Schaer, C. A., Yalamanoglu, A., Buzzi, R. M., Dubach, I. L., Tan, G., López-Cano, E. Y., Schulthess, N., Hansen, K., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137282 · Cited by 82
Pan, X., Wang, P., Luo, J., Wang, Z., Song, Y., Ye, J., & Hou, X. (2014) · Endocrine · doi:10.1007/s12020-014-0384-x · Cited by 86
A macrophage-hepatocyte glucocorticoid receptor axis coordinates fasting ketogenesis
Loft, A., Schmidt, S. F., Caratti, G., Stifel, U., Havelund, J., Sekar, R., Kwon, Y., Sulaj, A., Chow, K. K., Alfaro, A. J., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.004 · Cited by 76
Neto, H. A. P., Ausina, P., Gomez, L. S., Leandro, J. G. B., Zancan, P., & Sola‐Penna, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01478 · Cited by 85
Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
Bhat, N., & Mani, A. (2023) · Nutrients · doi:10.3390/nu15102323 · Cited by 92
Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease
Donates, Y. C., Lacraz, G., Ghobadi, F., Rakotoarivelo, V., Orkhis, S., Mayhue, M., Chen, Y.-G., Rola‐Pleszczynski, M., Menéndez, A., Ilangumaran, S., et al. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.020 · Cited by 86
Park, J.-M., Rah, S., An, H. S., Lee, J. Y., Roh, G. S., Ryter, S. W., Park, J. W., Yang, C. H., Surh, Y., Kim, U., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155516 · Cited by 79
Immunometabolism of AMPK in insulin resistance and atherosclerosis
Fullerton, M. D., Steinberg, G. R., & Schertzer, J. D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.004 · Cited by 77
Elsegood, C. L., Chan, C. W., Degli‐Esposti, M. A., Wikstrom, M. E., Domenichini, A., Lazarus, K., van Rooijen, N., Ganss, R., Olynyk, J. K., & Yeoh, G. C. T. (2015) · Hepatology · doi:10.1002/hep.27977 · Cited by 74
Integration of metabolomics, lipidomics and clinical data using a machine learning method
Acharjee, A., Ament, Z., West, J. A., Stanley, E. G., & Griffin, J. L. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1292-2 · Cited by 80
Kopec, A. K., Joshi, N., Towery, K., Kassel, K. M., Sullivan, B. P., Flick, M. J., & Luyendyk, J. P. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218545 · Cited by 78
Miyachi, Y., Tsuchiya, K., Komiya, C., Shiba, K., Shimazu, N., Yamaguchi, S., Deushi, M., Osaka, M., Inoue, K., Sato, Y., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.039 · Cited by 73
Zhao, J., Luo, D., Zhang, Z., Fan, N., Wang, Y., Nie, H., & Rong, J. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.026 · Cited by 78
Krüppel-Like Factors in Metabolic Homeostasis and Cardiometabolic Disease
Oishi, Y., & Manabe, I. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00069 · Cited by 89
Peiseler, M., & Tacke, F. (2021) · Cancers · doi:10.3390/cancers13040730 · Cited by 71
The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease
Nati, M., Chung, K.-J., & Chavakis, T. (2022) · Journal of Innate Immunity · doi:10.1159/000518407 · Cited by 71
Hepatic Macrophage as a Key Player in Fatty Liver Disease
Xu, L., Liu, W., Bai, F., Xu, Y., Liang, X., Ma, C., & Gao, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.708978 · Cited by 76
Immunomodulatory functions of FXR
Fiorucci, S., Zampella, A., Ricci, P., Distrutti, E., & Biagioli, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111650 · Cited by 70
Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice
Fourcot, A., Couchie, D., Chobert, M.-N., Zafrani, E.-S., Mavier, P., Laperche, Y., & Brouillet, A. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00311.2010 · Cited by 69
Bifari, F., Manfrini, R., Dei Cas, M., Berra, C., Siano, M., Zuin, M., Paroni, R., & Folli, F. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.025 · Cited by 69
Role of macrophages in experimental liver injury and repair in mice (Review)
Dong, X., Liu, J., Xu, Y., & Cao, H. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7450 · Cited by 68
The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update
Rakotoarivelo, V., Mayer, T. Z., Simard, M., Flamand, N., & Marzo, V. D. (2024) · Molecules · doi:10.3390/molecules29143381 · Cited by 83
Yimin, Furumaki, H., Matsuoka, S., Sakurai, T., Kohanawa, M., Zhao, S., Kuge, Y., Tamaki, N., & Chiba, H. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.159 · Cited by 72
Qin, G., Ma, J., Huang, Q., Yin, H., Han, J., Li, M., Deng, Y., Wang, B., Hassan, W., & Shang, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124126 · Cited by 75
Macrophages in nonalcoholic fatty liver disease: a role model of pathogenic immunometabolism
Krenkel, O., & Tacke, F. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1604480 · Cited by 66
The Interplay Between Tissue Niche and Macrophage Cellular Metabolism in Obesity
Daemen, S., & Schilling, J. D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03133 · Cited by 66
Epigenetic Regulation of Kupffer Cell Function in Health and Disease
Bennett, H., Troutman, T. D., Sakai, M., & Glass, C. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.609618 · Cited by 66
Macrophages in metabolic associated fatty liver disease
Alharthi, J., Latchoumanin, O., George, J., & Eslam, M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i16.1861 · Cited by 65
Hassan, W., Rongyin, G., Daoud, A., Ding, L., Wang, L., Liu, J., & Shang, J. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/313602 · Cited by 68
Henkel, J., Gärtner, D., Dorn, C., Hellerbrand, C., Schanze, N., Elz, S. R., & Püschel, G. P. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.47 · Cited by 70
Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis
Lee, S., Usman, T. O., Yamauchi, J., Chhetri, G., Wang, X., Coudriet, G. M., Zhu, C., Gao, J., McConnell, R., Krantz, K., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci154333 · Cited by 64
Motshakeri, M., Ebrahimi, M., Goh, Y. M., Othman, H. H., Hair-Bejo, M., & Mohamed, S. (2014) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2014/379407 · Cited by 64
Release of cytokines and hemodynamic instability during the reperfusion of a liver graft
Bezinover, D. S., Kadry, Z., McCullough, P., McQuillan, P. M., Uemura, T., Welker, K., Mastro, A. M., & Janicki, P. K. (2010) · Liver Transplantation · doi:10.1002/lt.22227 · Cited by 62
Chen, G., Ni, Y., Nagata, N., Zhuge, F., Xu, L., Nagashimada, M., Yamamoto, S., Ushida, Y., Fuke, N., Suganuma, H., et al. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900602 · Cited by 66
Hepatic Immune Microenvironment in Alcoholic and Nonalcoholic Liver Disease
Byun, J., & Yi, H. (2017) · BioMed Research International · doi:10.1155/2017/6862439 · Cited by 63
Carbohydrate and Amino Acid Metabolism as Hallmarks for Innate Immune Cell Activation and Function
Zhao, H., Raines, L. N., & Huang, S. C. (2020) · Cells · doi:10.3390/cells9030562 · Cited by 67
Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis
Overi, D., Carpino, G., Franchitto, A., Onori, P., & Gaudio, E. (2020) · Cells · doi:10.3390/cells9030590 · Cited by 66
Pardo, V., González-Rodríguez, Á., Guijas, C., Balsinde, J., & Valverde, Á. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.649483 · Cited by 60
Helminths, hygiene hypothesis and type 2 diabetes
de Ruiter, K., Tahapary, D. L., Sartono, E., Soewondo, P., Supali, T., Smit, J. W. A., & Yazdanbakhsh, M. (2016) · Parasite Immunology · doi:10.1111/pim.12404 · Cited by 62
Macrophage heterogeneity and energy metabolism
Verdeguer, F., & Aouadi, M. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.043 · Cited by 64
Chen, Y.-J., Wallig, M. A., & Jeffery, E. H. (2016) · Journal of Nutrition · doi:10.3945/jn.115.228148 · Cited by 68
Zhang, F., Jiang, W. W., Li, X., Qiu, X. Y., Wu, Z., Chi, Y. J., Cong, X., & Liu, Y. L. (2016) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12362 · Cited by 57
Zheng, W., Zhou, J., Song, S., Kong, W., Xia, W., Chen, L., & Zeng, T. (2018) · International Journal of Endocrinology · doi:10.1155/2018/8309723 · Cited by 60
Inflammation and Metabolic Complications in HIV
Bourgi, K., Wanjalla, C. N., & Koethe, J. R. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0411-2 · Cited by 63
Macrophage Subsets in Obesity, Aligning the Liver and Adipose Tissue
Remmerie, A., Martens, L., & Scott, C. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00259 · Cited by 57
García‐Martinez, I., Alén, R., Pereira, L., Povo‐Retana, A., Astudillo, A. M., Hitos, A. B., Gómez‐Hurtado, I., López‐Collazo, E., Boscá, L., Francés, R., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100756 · Cited by 70
CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice
Chen, G., Xu, R., Zhang, S., Wang, Y., Wang, P., Edin, M. L., Zeldin, D. C., & Wang, D. W. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00366.2014 · Cited by 60
Neutrophil heterogeneity and plasticity: unveiling the multifaceted roles in health and disease
He, W., Yan, L., Hu, D., Hao, J., Liou, Y., & Luo, G. (2025) · MedComm · doi:10.1002/mco2.70063 · Cited by 68
Metadata
- Authors
- Huang, W., Metlakunta, A., Dedousis, N., Zhang, P., Sipula, I., Dube, J. J., Scott, D. K., & O'Doherty, R. M.
- Affiliations
- University of Pittsburgh (US)
- Department of Medicine, Division of Endocrinology and Metabolism, University of Pittsburgh, Pittsburgh, Pennsylvania;
- Corresponding author
- O'Doherty, Robert M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-11-23
- Volume
- 59
- Issue
- 2
- Pages
- 347-357
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2809951
- OpenAlex
- W2138774651
- Cited by
- 520
- References
- 53
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 24 · 2023: 36 · 2022: 35 · 2021: 38 · 2020: 49 · 2019: 29 · 2018: 33 · 2017: 35 · 2016: 30 · 2015: 33 · 2014: 33 · 2013: 32 · 2012: 30
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK072162, R01DK065149, R01DK058855)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- Kupffer cells, hepatic macrophages, hepatic steatosis, insulin resistance, diet-induced obesity, type 2 diabetes, TNF-α, M1 macrophage polarization, hepatocyte lipid metabolism, fatty acid oxidation, triglyceride accumulation, innate immunity, high-fat diet, high-sucrose diet
- MeSH terms
- CD68 Molecule, Adipose Tissue, Animals, Antigens, Differentiation, Energy Intake, Dietary Fats, Fatty Liver, Gadolinium, Immunohistochemistry, Insulin Resistance, Kupffer Cells, Liver, Male, Membrane Glycoproteins, Sucrose, Antigens, Differentiation, Myelomonocytic, Glucose Clamp Technique, Antigens, CD, Rats, Wistar, Hepatocytes, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.